International journal of impotence research
-
Int. J. Impot. Res. · Oct 2004
Randomized Controlled Trial Clinical TrialOral terbutaline in the management of pharmacologically induced prolonged erection.
Prolonged erection and priapism are common complications following intracavernosal injection of vasoactive agents in the management of erectile dysfunction. It is usually treated by intracorporeal drainage and irrigation with sympathomimetic agents. ⋯ Detumescence was achieved in 42 and 15% of the cases with oral terbutaline and placebo, respectively. Results of this study suggest that an initial trial with oral terbutaline for pharmacologically induced prolonged erection may be successful.